Die neuesten NAVB Reports werden am 2023-11-14 aktualisiert: 2023-Q32022-Q42022-Q3
Navidea Biopharmaceuticals logo
Navidea Biopharmaceuticals NAVB
€ 0.07 -2.99%

Navidea Biopharmaceuticals Kennzahlen 2011-2024 | NAVB

Kennzahlen Jährlich Navidea Biopharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.6 -2.4 -4.9 -1.6 -1.4 0.8 -4.9 -4.6 -6.7 -4.9 -10.8 44.2

P/S

136.5 53.6 56.9 26.5 19.0 32.1 3.2 9.5 38.2 186.4 4000.7 414.9

EPS

-0.6 -0.4 -0.5 -0.8 -0.1 0.5 -0.1 -0.2 -0.2 -0.3 -0.3 0.1

EV (Enterprise Value)

19.5 M 30.3 M 55.1 M 21.4 M 23.3 M 64.1 M 149 M 187 M 276 M 222 M 319 M 229 M

EBITDA per Share

-0.45 -0.41 -0.445 -0.752 -1.25 -1.69 -0.222 -2.38 -3.65 -6.24 -5.61 -5.29

EV/EBITDA

-0.1 -4.7 -1.5 -1.8 -4.2 -75.5 -10.0 -9.9 -5.4 -11.4 -9.4

PEG

0.03 -0.02 -2.45 -0.03 0.01 0.0 -0.1 -0.18 -0.21 0.24 0.02 0.41

P/B

-1.1 45.6 39.6 -10.8 12.7 5.1 -1.0 -2.3 -8.0 -52.6 -224.1 11.7

P/CF

-1.0 -2.8 -6.1 -1.9 5.2 1.0 19.7 -6.6 -7.9 -5.7 -12.8 -15.3

ROE %

179.91 11009.17 -814.96 679.05 -924.95 658.60 21.00 50.76 119.87 1064.93 2074.69 26.56

ROA %

-347.18 -176.54 -138.20 -263.75 -229.49 360.64 -114.82 -184.19 -299.72 -105.91 -243.54 17.99

ROCE %

166.56 11318.38 -352.00 -3308.39 -297.76 -109.16 3.87 -211.27 -978.13 -132.43 -484.09 -86.57

Current Ratio

0.3 1.1 1.4 0.8 1.7 1.7 0.2 2.0 0.9 3.3 1.7 9.0

DSO

260.3 1057.7 1191.6 500.1 6.6 1640.7 29.9 102.0 47.5 371.5 81.6 9.6

DIO

54392.6 - 59137.7 - - - 233.7 135.8 214.6 2448.3 - -

DPO

333206.4 - 404605.6 60882.7 1604.2 85480.9 1131.9 367.7 340.0 2656.6 - -

Betriebszyklus

54652.9 1057.7 60329.3 500.1 6.6 1640.7 263.7 237.8 262.1 2819.8 - -

Finanzkreislauf

-278553.5 1057.7 -344276.3 -60382.6 -1597.6 -83840.2 -868.2 -129.8 -77.9 163.2 - -

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Navidea Biopharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.02 0.12 -0.05 - -0.25 -0.1 -0.1 - -0.08 -0.09 -0.11 - -0.13 -0.11 -0.13 - -0.17 -0.24 -0.24 - -0.02 -0.02 -0.83 -0.03 -0.01 -0.03 0.53 -0.03 -0.07 -0.04 -0.02 -0.02 -0.05 -0.06 -0.05 -0.05 -0.05 -0.07 -0.08 -0.1 -0.09 -0.09 -0.06 -70 -90 -60 -70 - 0.21 -0.02 -0.05

EBITDA per Share

-0.02 -0.05 -0.07 - -0.16 -0.1 -0.1 - -0.08 -0.09 -0.12 - -0.11 -0.1 -0.13 - -0.16 -0.23 -0.24 - -0.02 -0.01 -0.3 -0.02 -0.01 -0.03 -0.02 -0.02 - -0.01 -0.02 -0.02 -0.03 -0.02 -0.04 -0.03 -0.03 -0.06 -0.06 -0.1 -0.08 -0.07 -0.06 -0.06 -0.09 -0.06 -0.07 - -0.07 -0.04 -0.05

ROE %

-352.29 -298.91 330.79 334.64 275.67 94.40 -17.87 -159.75 -380.13 -541.54 -676.77 -600.38 -409.71 1.34 343.91 507.13 287.75 -122.30 -425.52 -743.56 -779.22 -572.05 -480.22 658.60 699.96 712.25 767.64 21.00 19.93 34.70 42.74 50.76 69.17 77.45 93.91 119.87 439.82 698.64 921.23 1064.92 1234.48 1599.92 1758.21 2072.43 1653.75 1100.19 674.65 62.56 93.85 -10.36 -20.93

ROA %

-119.75 -171.38 -364.56 -293.93 -321.14 -257.15 -161.05 -80.35 -117.73 -127.89 -134.16 -101.81 -175.87 -212.56 -246.98 -196.98 -251.41 -231.78 -201.48 -184.49 -204.02 -156.27 -147.14 360.64 349.01 355.22 326.57 -114.82 -100.44 -153.90 -165.05 -184.19 -225.45 -229.83 -251.48 -301.25 -277.33 -247.05 -186.19 -105.91 -131.96 -179.92 -203.10 -243.27 -119.53 20.04 61.76 42.38 63.58 -7.02 -14.18

ROCE %

421.55 462.50 306.45 316.23 257.65 92.99 -17.41 -166.54 -386.86 -548.61 -685.04 -601.29 -409.98 1.65 345.31 508.00 294.40 -110.50 -415.47 -496.27 -527.21 -334.58 -237.75 -121.96 -86.26 -63.96 -18.28 14.90 16.52 24.23 27.28 33.96 42.60 51.55 76.13 92.72 403.25 632.78 812.76 958.65 1133.04 1530.82 1703.24 1991.50 1460.93 784.99 384.70 -71.28 -30.63 -16.98 -23.67

Current Ratio

0.7 0.9 0.2 0.3 0.6 0.4 0.6 1.1 1.9 2.3 2.0 1.4 1.4 1.4 1.4 0.8 0.8 0.8 0.8 1.5 1.5 1.5 1.5 2.4 2.4 2.4 2.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.9 0.9 0.9 0.9 0.9 0.9 0.9 0.9 3.1 3.1 3.1 3.1

DSO

- - - - - - - - - - 1101.5 - - 285.3 758.1 - 68.0 194.4 1011.2 - 8.3 3.6 1346.6 - 3320.0 1214.2 656.1 - 10.2 15.9 10.3 - 42.9 70.7 50.4 71.3 94.6 71.2 143.2 174.1 415.1 821.4 - - - - - - 365.7 29.3 -

DIO

- - - - 16232.4 61604.6 - - - - - - 188952.0 43400.8 12720.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - 132706.6 385023.4 - - - - - - 1292764.3 296937.5 170347.3 - 520391.3 426371.0 11445.6 - 1017.2 1095.0 183613.5 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - - - 16232.4 61604.6 - - - - 1101.5 - 188952.0 43686.1 13479.1 - 68.0 194.4 1011.2 - 8.3 3.6 1346.6 - 3320.0 1214.2 656.1 - 10.2 15.9 10.3 - 42.9 70.7 50.4 71.3 94.6 71.2 143.2 174.1 415.1 821.4 - - - - - - 365.7 29.3 -

Finanzkreislauf

- - - - -116474.2 -323418.8 - - - - 1101.5 - -1103812.3 -253251.4 -156868.2 - -520323.3 -426176.6 -10434.5 - -1008.8 -1091.5 -182266.9 - 3320.0 1214.2 656.1 - 10.2 15.9 10.3 - 42.9 70.7 50.4 71.3 94.6 71.2 143.2 174.1 415.1 821.4 - - - - - - 365.7 29.3 -

Alle Zahlen in USD-Währung